Connect
MJA
MJA

Seizures related to praziquantel therapy in neurocysticercosis

Saliya S Hewagama, Jonathan D Darby, Harsha Sheorey and John R Daffy
Med J Aust 2010; 193 (4): . || doi: 10.5694/j.1326-5377.2010.tb03885.x
Published online: 16 August 2010

To the Editor: Seizures can be precipitated by treatment with praziquantel in patients with underlying neurocysticercosis, but this is rare and has not previously been described in Australia. We describe the case of a patient who developed seizures after antischistosomal therapy.


  • St Vincent’s Hospital, Melbourne, VIC.


Correspondence: Jonathan.Darby@svhm.org.au

  • 1. Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005; 4: 653-661.
  • 2. Das K, Mondal GP, Banerjee M, et al. Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomized study. J Clin Neurosci 2007; 14: 1172-1177.
  • 3. Del Brutto OH, Roos KL, Coffey CS, et al. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006; 145: 43-51.
  • 4. Murray R, Davis J, Krause V, et al; Australasian Society for Infectious Diseases Refugee Health Guidelines Writing Group. Diagnosis, management and prevention of infections in recently arrived refugees. Sydney: Dreamweaver Publishing, 2009; 29. http://www.asid.net.au/downloads/RefugeeGuidelines.pdf (accessed Jul 2010).
  • 5. Dorny P, Brandt J, Zoli A, et al. Immunodiagnostic tools for human and porcine cysticercosis. Acta Tropica 2003; 87: 79-86.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.